LACK OF CLINICALLY SIGNIFICANT INVITRO AND INVIVO INTERACTIONS BETWEEN RANITIDINE AND SUCRALFATE

被引：18
|
作者：
MULLERSMAN, G [1 ]
GOTZ, VP [1 ]
RUSSELL, WL [1 ]
DERENDORF, H [1 ]
机构：
[1] UNIV FLORIDA,J HILLIS MILLER HLTH CTR,COLL PHARM,GAINESVILLE,FL 32610
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1986年 / 75卷 / 10期
关键词：
D O I：
10.1002/jps.2600751018
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：995 / 998
页数：4
相关论文
共 50 条
  • [1] INVITRO AND INVIVO INTERACTIONS BETWEEN RANITIDINE AND SUCRALFATE
    MULLERSMAN, G
    GOTZ, VP
    RUSSELL, WL
    DERENDORF, H
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 452 - 452
  • [2] INVITRO AND INVIVO INTERACTIONS OF FUROSEMIDE AND SUCRALFATE
    HIKAL, AH
    WALKER, LA
    RAMACHANDRAN, T
    PHARMACEUTICAL RESEARCH, 1987, 4 (02) : 171 - 172
  • [3] Lack of clinically significant drug interactions between pioglitazone and theophylline
    Stubbs, C
    Glazer, B
    Cao, C
    Cheatham, W
    DIABETES, 2002, 51 : A478 - A478
  • [4] Lack of Clinically Significant Drug Interactions between Nevirapine and Buprenorphine
    McCance-Katz, Elinore F.
    Moody, David E.
    Morse, Gene D.
    Ma, Qing
    Rainey, Petrie M.
    AMERICAN JOURNAL ON ADDICTIONS, 2010, 19 (01): : 30 - 37
  • [5] Lack of clinically significant interactions between frovatriptan and ergotamine.
    Buchan, P
    Ward, C
    Oliver, SD
    CEPHALALGIA, 1999, 19 (04) : 364 - 364
  • [6] Lack of clinically significant interactions between concomitantly administered rasagiline and escitalopram
    Hilli, Johanna
    Korhonen, Tuomas
    Laine, Kari
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (08): : 1526 - 1532
  • [7] CLINICALLY SIGNIFICANT SUCRALFATE WARFARIN INTERACTION IS NOT LIKELY
    NEUVONEN, PJ
    JAAKKOLA, A
    TOTTERMAN, J
    PENTTILA, O
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (02) : 178 - 180
  • [8] Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects
    Teng, R.
    Butler, K.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (06) : 704 - 711
  • [9] Lack of clinically significant pharmacokinetic drug interactions between RWJ-333369 and valproate or lamotrigine
    Chien, SC
    Yao, CP
    Mertens, A
    Verhaeghe, T
    Solanki, B
    Doose, D
    Novak, G
    EPILEPSIA, 2005, 46 : 173 - 173
  • [10] Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy
    Levy, RH
    Ragueneau-Majlessi, I
    Brodie, MJ
    Smith, DE
    Shah, D
    Pan, WJ
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 193 - 198
12345